drugset / Trial / NCT01655082

Nicotine Patch Safety Study

NCT01655082

Phase 2 Completed 160 enrolled Pierre Fabre Laboratories
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety profile of a repeated application of a new transdermal patch compared to a reference product during 3 weeks, in a large population.

Timeline

Start
2012-08
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown Other
Subject V0116 Unknown Other

Indications

No indication recorded.